Akebia Therapeutics | AKBA - 市值



金融业
股票价格
USD
资产
USD 362.52M
现金及等价物
USD 162.64M
销售成本
USD 10.34M
流动资产
USD 243.48M
流动负债
USD 173.88M
债务
USD 46.51M
股息收益率
0
EBIT
USD -5.45M
EBITDA
USD 14.03M
员工
167
EPS每股收益
USD -0.04
股本和储备
USD 27.38M
销售毛利
USD 47.28M
债务利息支出
362.52M
贷款资金
USD 36.4M
市值
USD 224M
净收入
USD -12.24M
营业费用
USD 63.08M
营业利润
USD -5.45M
普通股股本
USD 265.43M
PE价格收益
1.63K
税前利润
USD -11.24M
销售收入
USD 57.62M
销售和管理费用
USD 23.53M
股票
USD 13M
贸易债权人
USD 8.39M
应收帐款人
USD 47.03M


市值 更改 日
Acadia Pharmaceuticals USD 3.8B 724M 2026-03
Agios Pharmaceuticals USD 2.01B 423M 2026-03
Akebia Therapeutics USD 427M 297M 2025-12
Alnylam Pharmaceuticals USD 44.15B 8.39B 2026-03
Amgen USD 189.89B 13.64B 2026-03
Astellas Pharma JPY 4.56T 770.92B 2026-03
AstraZeneca USD 301.25B 13.1B 2026-03
Bayer EUR 38.69B 2.33B 2026-03
BioMarin Pharmaceutical USD 10.86B 553M 2026-03
Deva Holding AS TRY 17.54B 7.76B 2023-09
Dianthus Therapeutics USD 1.78B 215M 2025-12
Exelixis USD 10.89B 857M 2026-03
Fresenius Medical Care EUR 11.32B 642.58M 2026-03
GlaxoSmithKline GBP 83.8B 9.44B 2026-03
Ionis Pharmaceuticals USD 12.46B 356M 2026-03
J&J USD 579.15B 78.91B 2026-03
Kangmei Pharma CNY 24.48B 3.45B 2026-03
Karyopharm Therapeutics USD 1.05B 912M 2026-06
Laboratorios Farma EUR 4.17B 917.16M 2026-03
Lexicon Pharmaceuticals USD 418M 73M 2025-12
Malin Corporation EUR 142.92M 19.65M 2026-02
Medical Developments International AUD 62.53M 563.29K 2025-12
Moderna USD 20.15B 8.53B 2026-03
Nektar Therapeutics USD 11.91B 11.05B 2026-06
Neuren Pharmaceuticals AUD 2.36B 606.56M 2025-12
Organigram Holdings CAD 312.16M 66.64M 2025-12
Ovoca Bio EUR 6.12M 4.93M 2026-04
Pharma Mar EUR 1.57B 225M 2026-03
PTC Therapeutics USD 5.64B 460M 2026-03
Qiagen NV USD 8.27B 1.62B 2026-03
Regeneron Pharmaceuticals USD 81.68B 560M 2026-03
Roche Holding CHF 266.34B 55.46B 2025-12
Sanofi EUR 100.27B 605.48M 2026-03
Sarepta Therapeutics USD 2.28B 30M 2026-03
Sartorius EUR 14.25B 2.16B 2026-03
Tectonic Therapeutic USD 390M 96M 2025-12
Vanda Pharmaceuticals USD 279M 6M 2024-12
Zealand Pharma A/S 33.35B 448.34M 2025-12